Postmarketing Safety Surveillance of a Hexavalent Vaccine in the Vaccine Adverse Event Reporting System - 08/11/23
, Bicheng Zhang, MS 1, Paige Marquez, MSPH 1, Jonathan Reich, MD, MSc 2Abstract |
We assessed the safety of hexavalent vaccine diphtheria and tetanus toxoids and acellular pertussis, inactivated poliovirus, hepatitis b, and haemophilus influenzae b conjugate vaccine in the Vaccine Adverse Event Reporting System. Five hundred-one reports of adverse events (AEs) were identified; 21 (4.2%) were serious. Most frequently reported AEs were fever (10.2%) and injection site erythema (5.4%). AEs reported were consistent with findings from prelicensure studies.
Le texte complet de cet article est disponible en PDF.Keywords : epidemiology, hexavalent vaccine, surveillance, vaccine safety
Abbreviations : CDC, FDA, DTaP-IPV-Hib-HepB, VAERS, MedDRA, PT
Plan
| Disclaimer: The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention or the US Food and Drug Administration. |
Vol 262
Article 113643- novembre 2023 Retour au numéro
Article précédent
- Longitudinal Associations Between Perceived Discrimination and Suicidality in Youth
- Arielle T. Pearlman, Mikela A. Murphy, Sorana Raiciulescu, Nia Johnson, David A. Klein, Joshua C. Gray, Natasha A. Schvey
- Bilious Worm Emesis Secondary to Intestinal Helminthic Infection
- Andrea Lauffer, Mariana Lanata Piazzon, Francesca Giovannone, Susan Flesher, Jacob T. Kilgore
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?